[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=”1″ use_custom_gutter=”on” gutter_width=”2″ specialty=”on” parallax_method_1=”off” parallax_method_2=”off” _builder_version=”3.0.74″ transparent_background=”off” prev_background_color=”#000000″ next_background_color=”#1d1d1d”][et_pb_column type=”1_3″][et_pb_sidebar admin_label=”Left Nav Sidebar” area=”et_pb_widget_area_1″ show_border=”off” module_id=”left-nav-menu” _builder_version=”3.12.1″]<\/p>\n
[\/et_pb_sidebar][\/et_pb_column][et_pb_column type=”2_3″ specialty_columns=”2″][et_pb_row_inner admin_label=”Row” _builder_version=”3.0.47″][et_pb_column_inner type=”4_4″ saved_specialty_column_type=”2_3″][et_pb_text _builder_version=”3.17.6″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” module_alignment=”left” use_border_color=”off”]<\/p>\n
PROTECT COVID-19 Symposium<\/h1>\n
On 5-6 May 2022, researchers from across the PROTECT COVID-19 National Core Study on transmission and environment came together in London for the programme’s second major meeting.<\/p>\n
The PROTECT Researcher Symposium 2022 marks the beginning of a new phase of the PROTECT programme, with the emphasis shifting from primary research activities to translational work, ensuring the results and learnings from our work are accessible and applicable by key stakeholder and end users. The event:\u00a0<\/p>\n
- \n
- Provided an opportunity for the PROTECT research community to come together to discuss and shape the direction of travel of this next phase, as well as sharing and reflecting back on the work of the PROTECT programme to date.\u00a0<\/li>\n
- Provided further opportunities for PROTECT researchers to connect and engage with each other cross-theme and cross-discipline.\u00a0<\/li>\n
- Provided Continuing Professional Development opportunities for PROTECT researchers of particular relevance to this next phase of the programme.\u00a0<\/li>\n
- Allowed for enhanced awareness of PROTECT\u2019s place within the wider National Core Studies programme.\u00a0<\/li>\n<\/ul>\n
Day 1 opened with a plenary talk from Professor Andrew Curran entitled “Securing our legacy: PROTECT\u2019s final year and the transition to a longer-term solution for UK research capacity on respiratory disease transmission”, which was followed by stakeholder perspectives, and\u00a0lightning talks grouped around the areas of modelling & transmission,\u00a0COVID-19 prevalence, and experimental measurements.<\/p>\n
Plenary session 2 started with Sir Patrick Vallance as he reflected on the National Core Studies (NCS) programme as a whole<\/a><\/span>.\u00a0 Additional talks focused on data and connectivity, epidemiology and surveillance and longitudinal health and wellbeing.\u00a0 The day ended with 23 five-minute lightning talks.<\/p>\n
Day 2 opened with a session to discuss cross-disciplinary collaborations around strategies to evaluate and improve ventilation, a deep-dive into Covid-19 transmission risk and mitigations in nuclear power stations in the UK and, looking at mitigations – taking results from modelling for application to the real world.<\/p>\n
Final plenary talks were around securing funding for COVID-19 and other respiratory virus transmission research, accessing data via the ONS secure research service and, maximising policy impact.<\/p>\n
[\/et_pb_text][et_pb_button admin_label=”Button:Sir Patrick Vallance” button_url=”https:\/\/www.youtube.com\/watch?v=bYL42-9C8Dw” button_text=”Watch: Reflections on the National Core Studies, with Sir Patrick Vallance” _builder_version=”3.17.6″]<\/p>\n
[\/et_pb_button][et_pb_text admin_label=”Title: Programme” _builder_version=”3.17.6″]<\/p>\n
Symposium Programme<\/h2>\n
[\/et_pb_text][et_pb_accordion admin_label=”Accordion: Programme” _builder_version=”3.17.6″ border_color_all=”#ffffff” use_border_color=”off”][et_pb_accordion_item title=”Programme Day 1 – Thursday 5th May 2022 ” open=”on” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Plenary 1: Making PROTECT Count for Our Stakeholders
<\/strong>Chair: Professor Andrew Curran, Chief Scientific Adviser, Health and Safety Executive
<\/em><\/h4>\nSecuring our legacy: PROTECT\u2019s final year and the transition to a longer-term solution for UK research capacity on respiratory disease transmission
Professor Andrew Curran, Chief Scientific Adviser, Health and Safety Executive
<\/em><\/p>\nStakeholder perspectives<\/strong><\/h5>\n
Seizing the opportunity for long term change<\/strong>
Dr Alexandra Smyth, Senior Policy Adviser, Royal Academy of Engineering
<\/em>Download PDF: Seizing the opportunity for long term change<\/a><\/span><\/p>\nWhere have all the lifeboats gone? Learning from lockdown<\/strong>
Steve Sylvester, Acting Head of Public Protection, Lancaster City Council
<\/em>Download PDF: Where have all the lifeboats gone? Learning from lockdown<\/a><\/span><\/p>\nHSE: How Science Supported Policy and Regulation during the Pandemic<\/strong>
Dr John Rowe, Acting Head of Operational Strategy Branch, Engagement & Policy Division, Health and Safety Executive
<\/em>Download PDF: HSE: How Science Supported Policy and Regulation during the Pandemic<\/span><\/a><\/p>\nResponding to stakeholder needs: Understanding of the role of ventilation<\/strong>
Professor Cath Noakes, University of Leeds<\/em><\/p>\nPlenary 2: PROTECT in Context: The National Core Studies Programme
<\/strong>Chair: Professor Andrew Curran, Chief Scientific Adviser, Health and Safety Executive<\/em><\/h4>\nReflections on the National Core Studies (NCS) programme
<\/strong>Sir Patrick Vallance, Chief Scientific Adviser, UK Governmen<\/em>t
<\/em>Watch the video: Reflections on the National Core Studies (NCS) programme<\/a><\/span><\/p>\nData and Connectivity NCS<\/strong>
Lara Edwards, Senior Programme Manager, Health Data Research UK
Dr Steven Kerr, Senior Research Fellow, University of Edinburgh
<\/em>Download PDF: Data and Connectivity NCS<\/a><\/span><\/p>\nEpidemiology and Surveillance NCS<\/strong>
Dr Tristan Pett,Covid-19 Infection Survey, Analytical Development Lead, ONS
Dr Katie Cunliffe, Covid-19 Infection Survey, Senior Research Officer, ONS
<\/em>Download PDF: Epidemiology and Surveillance NCS<\/a><\/span><\/p>\nLongitudinal Health and Wellbeing NCS<\/strong>
Dr Chloe Park, Senior Communications Manager, University College London
Dr Ellen Thompson, Postdoctoral Research Associate, King\u2019s College London
Dr Milla Kibble, Research Facilitator, University of Cambridge
Download PDF: Longitudinal Health and Wellbeing NCS<\/a><\/span><\/em><\/p>\n<\/h4>\n
Parallel sessions: PROTECT Research Lightning Talks<\/strong><\/h4>\n
[\/et_pb_accordion_item][et_pb_accordion_item title=”Programme Day 2 – Friday 6th May 2022″ open=”off” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Parallel Session 2.1: Cross-disciplinary Collaboration Workshops<\/strong><\/h4>\n
Workshop A: Strategies to evaluate and improve ventilation<\/strong>
Lead: Professor Cath Noakes, University of Leeds Cambridge<\/em><\/p>\nWorkshop B: Understanding viral emission rates and dose-response at the micro-level<\/strong>
Lead: Mr Allan Bennett, UK Health Security Agency & Dr Simon Parker, Defence Science and Technology Laboratory<\/em> and<\/p>\nParallel Session 2.2: Cross-disciplinary Collaboration Workshops<\/strong><\/h4>\n
Workshop C: Deep-dive into Covid-19 transmission risk and mitigations in nuclear power stations in the UK<\/strong>
Lead: Professor Martie Van Tongeren, University of Mancheste<\/em>r<\/p>\nWorkshop D: Looking at Mitigations, taking results from modelling for application to real World<\/strong>
Lead: Professor Cath Noakes, University of Leeds, & Dr Yiqun Chen, HSE<\/em><\/p>\nPlenary Session 3: CPD\/skills Talks
<\/strong>Chair: Professor Andrew Curran, Chief Scientific Adviser, Health and Safety Executive<\/em><\/h4>\nSecuring funding for COVID-19 and other respiratory virus transmission research<\/strong>
Dr Jennifer Anderson, Head of Training and Careers, UKRI, Medical Research Council
<\/em>Download PDF: Securing funding for COVID-19 and other respiratory virus transmission research<\/a><\/span><\/p>\nDr Jennifer Anderson is Head of Training and Careers (MRC). Her role involves overseeing MRC\u2019s strategy for, and investment
![\"Headshot](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/Jennifer_Anderson_circ.png\")
in, studentships and personal fellowships to ensure we train, attract and retain the skilled individuals that make the UK a leader in biomedical research. Prior to joining MRC in 2015, she completed a PhD in cancer cell biology and spent 8 years as a postdoc researching radiation biology.<\/p>\nAccessing Data via the ONS Secure Research Service<\/strong>
Dr Beth Routley, Senior Researcher, Secure Research Service,ONS
<\/em><\/p>\nClosing Plenary<\/strong><\/h4>\n
Wrap-up and reflections; announcement and presentation of award for best poster presentation (as voted for by fellow PROTECT researchers during the event)
Professor Andrew Curran, Chief Scientific Adviser, Health and Safety Executive<\/em><\/p>\nLightening Talks – Groupings by Session<\/strong><\/h4>\n
[\/et_pb_accordion_item][\/et_pb_accordion][et_pb_button admin_label=”Button: Symposium Programme” button_url=”https:\/\/documents.manchester.ac.uk\/display.aspx?DocID=61843″ button_text=”Download a PDF of the programme” _builder_version=”3.17.6″]<\/p>\n
[\/et_pb_button][et_pb_text admin_label=”Title: Speakers” _builder_version=”3.17.6″]<\/p>\n
Speakers<\/h2>\n
[\/et_pb_text][et_pb_accordion admin_label=”Accordion: Speakers” _builder_version=”3.17.6″ border_color_all=”#ffffff” use_border_color=”off”][et_pb_accordion_item title=”Day 1″ open=”on” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Chair: Professor Andrew Curran, Chief Scientific Adviser, Health and Safety Executive<\/h3>\n
Professor Andrew Curran is the Chief Scientific Adviser (CSA) and Director of Research at the Health and Safety Executive (HSE).
![\"Round](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2021\/10\/Andrew-Curran_circ.png\")
During his 29-year career with HSE he has been a bench scientist, has led a number of teams, and has a significant publication record in the field of occupational health and safety. He has responsibility for ensuring that HSE has access to the evidence it needs to underpin policy and regulatory decision making. He is also Head of Profession for HSE\u2019s scientists, engineers and physicians, and sits on the Government\u2019s GSE Professions Board, where he is also Deputy Head of the Profession under Sir Patrick Vallance. Andrew is part of the Government CSA network, and during the COVID-19 pandemic has been an active participant in the Scientific Advisory Group for Emergencies (SAGE), as well as leading the PROTECT National Core Study. He has oversight of HSE\u2019s Scientific Advisory Committee on Workplace Health, is the Chair of the Sheffield Group (the global network of national health and safety research organisations), a member of the Steering Group of PEROSH (the Partnership for European Research in Occupational Safety and Health), and supports HSE\u2019s role as a Collaborating Centre in Occupational Safety and Health. Andrew is also a Fellow of the Royal Society of Biology and the Chartered Management Institute, an Honorary Fellow of the UK Faculty of Occupational Medicine, and an Honorary Professor at the universities of Sheffield and Manchester, where he co-Directs the Centre for Workplace Health and the Thomas Ashton Institute for Risk and Regulatory Research respectively.<\/p>\nDr Alexandra Smyth, Senior Policy Adviser, Royal Academy of Engineering<\/h3>\n
Steve Sylvester, Commercial Protection Manager and Acting Head of Public Protection, Lancaster City Council<\/h3>\n
Steve qualified as an Environmental Health Officer (EHO) from Salford University in 1990 and has spent the last 30 years working across
![\"Headshot](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/steven_Sylveste_circ.png\")
a number of Local Authorities in Public Protection delivering operational services covering Food Safety, Health and Safety, Housing Standards, and Environmental Protection, before taking up various management positions eventually bringing him to Lancaster City Council as the Commercial Protection Manager responsible for Food Safety, Health & Safety and Licensing in 2014. <\/p>\nHe has written a number of published articles relating to food fraud and crime for an Environmental Health Journal, as well as developing the nationally recognised Covid Safe assurance scheme for businesses and the recently Launched \u201cEat safe\u201d and \u201cDrink Safe\u201d customer assurance scheme for Lancaster. Steve had a lead role jointly with the Head of Public Protection coordinating the Council\u2019s public response to the Pandemic, and has recently taken up a temporary position sharing the post of Head of Public Protection at Lancaster.<\/p>\n
Dr John Rowe, Acting Head of Operational Strategy Branch, Engagement & Policy Division, Health and Safety Executive<\/h3>\n
John is currently Acting Head of Operational Strategy in the Health & Safety Executive (HSE) with responsibility for policy and HSE\u2019s
![\"\"](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/patrick-vallance_circ-1.png\")
operational direction in most industrial sectors. He has worked for HSE for over 20 years as an inspector, Principal Inspector and Head of Operations in Yorkshire & North East. John has undertaken or overseen numerous inspections, investigations and prosecutions but is now interested in how HSE can work in partnership with industry; particularly to reduce the burden of occupational ill health on GB. John worked on HSE\u2019s policy and operational response to COVID-19 throughout the pandemic.<\/p>\nProfessor Cath Noakes, University of Leeds<\/h3>\n
Professor Cath Noakes OBE is a chartered mechanical engineer, with a background in fluid dynamics. She leads research into
![\"round](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2021\/10\/Cath-Noakes_circ.png\")
ventilation, indoor air quality and infection control in the built environment. Her research focuses on experimental and modelling based studies, to explore the transport of airborne pathogens, the influence of indoor airflows, and the effectiveness of engineering approaches to controlling airborne disease transmission, including within healthcare settings. Cath is currently Deputy Director of Leeds Institute for Fluid Dynamics, and Co-Director of the EPSRC Centre for Doctoral Training in Fluid Dynamics. Since April 2020 she has been involved in the UK\u2019s COVID-19 response, leading the Environment and Modelling sub-group of the Scientific Advisory Group for Emergencies (SAGE), focusing on the science underpinning environmental transmission of COVID-19. Cath leads Theme 2 of the PROTECT study.<\/a><\/span><\/p>\nSir Patrick Vallance, Chief Scientific Adviser, UK Government<\/h3>\n
Sir Patrick Vallance<\/a><\/span> FRS<\/abbr> FMedSci<\/abbr> FRCP<\/abbr> is Government Chief Scientific Adviser (GCSA<\/abbr>), Head of the Government Science and
![\"\"](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/patrick-vallance_circ.png\")
Engineering (GSE<\/abbr>) Profession and National Technology Adviser (NTA<\/abbr>). His personal research was in the area of diseases of blood vessels and endothelial biology. Patrick was President, R&D<\/abbr> at GlaxoSmithKline (GSK<\/abbr>) from 2012 until 2017. Prior to this, he was Senior Vice President, Medicines Discovery and Development. He joined the company in May 2006 as Head of Drug Discovery. He was a member of the GSK<\/abbr> Board and the Corporate Executive Team. During his period as head of R&D<\/abbr> over 14 new medicines were approved for use worldwide, for diseases ranging from cancer to asthma and HIV. Prior to joining GSK<\/abbr>, he was a clinical academic, Professor of Medicine and led the Division of Medicine at UCL<\/abbr>. He has over 20 years\u2019 experience of basic and clinical research, and was a consultant physician in the NHS. His research spanned from work on medicinal chemistry and structural biology, through to cellular work, studies in humans and use of large electronic health record databases. He was elected to the Academy of Medical Sciences in 1999 and to the Royal Society in 2017. He was on the Board of the UK Office for Strategic Co-ordination of Health Research (OSCHR<\/abbr>) from 2009 to 2016. He is an Honorary Fellow at UCL<\/abbr> and holds honorary degrees from Imperial College London, Glasgow University, University of York and St George\u2019s, University of London. He was a non-executive director and board member for UK Biobank and a non-executive board member for Genome Research Limited but stepped down in taking up the GCSA<\/abbr> role.<\/p>\nLara Edwards, Senior Programme Manager, Health Data Research UK<\/h3>\n
As Senior Programme Manager for National Core Study Data and Connectivity, Lara\u2019s role is to ensure the successful development and
![\"\"](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/Lara-Edwards_circ.png\")
delivery of the Data and Connectivity work programme, by working closely with study leads at HDR UK and ONS, co-ordinating study activities and managing progress across a complex programme of activities delivered in partnership with key national organisations. The NCS Data and Connectivity programme aims to address the current fragmentation of the UK data infrastructure by working in partnership with stakeholders from across the four nations to organise medical, biological and social science data on an unprecedented scale and complexity. Lara joined HDR UK<\/a><\/span> from NIHR Applied Research Collaboration West, where she was responsible for efficient overall management of the ARC programme, working with a diverse group of regional and national stakeholders. Previously, she has held various senior programme and trial management roles across the NIHR clinical research infrastructure, and before this held roles in laboratory science (microbiology) and management.<\/p>\nDr Steven Kerr, Senior Research Fellow, University of Edinburgh<\/h3>\n
Dr Steven Kerr<\/a><\/span> is a senior research fellow in the Centre for Medical Informatics at the Usher Institute, University of Edinburgh. Initially he worked on theoretical particle physics (lattice QCD), but then switched to quantum gravity (topological quantum field theory and state sum models), before working in the private sector as a data scientist, which he continues today. Currently, he is involved in research on the epidemiology of COVID-19 through EAVE II<\/a><\/span>, which is a data platform consisting of clinical and demographic information for the entire population of Scotland, which has published a number of important research articles<\/a> <\/span>on COVID-19 vaccine effectiveness and safety. on COVID-19 vaccine effectiveness and safety.<\/p>\n
Dr Tristan Pett,Covid-19 Infection Survey, Analytical Development Lead, ONS<\/h3>\n
Tristan Pett is a Principal Statistician in the UK Government Statistician Group. He has worked for the past two years developing analysis
![\"Headshot](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/Tristan-headshot_circ.png\")
on the Office for National Statistics\u2019 Coronavirus (COVID-19) Infection Survey, most recently leading bespoke analysis to inform policy responses to the pandemic. Tristan has a background in environmental science academia and the third sector, his research applying interdisciplinary approaches to understand the value of nature for human health and well-being.<\/p>\nDr Katie Cunliffe, Covid-19 Infection Survey, Senior Research Officer, ONS<\/h3>\n
Katie Cunliffe is a Senior Researcher for the UK Government Social Research Profession, currently working on the Office for National
![\"Headshot](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/Katie_Cunliffe_circ.png\")
Statistics\u2019 gold standard Coronavirus (COVID-19) Infection Survey delivering bespoke analyses to inform the UK Government\u2019s response to the pandemic and the general public. With a professional background in third sector leadership and education sector strategy and governance, her personal research explored professionalism using mixed methodologies through the lens of psychometric theory.<\/p>\nDr Chloe Park, Senior Communications Manager, University College London<\/h3>\n
Dr Ellen Thompson, Postdoctoral Research Associate, King\u2019s College London<\/h3>\n
Dr Ellen Thompson<\/a><\/span> is a Postdoctoral Research Associate working across The Department of Twins Research & Genetic Epidemiology
![\"\"](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/ellen-thompson_circ.png\")
(DTR) and The Social, Genetic and Developmental Psychiatry (SGDP) Centre. Her current research focusses on investigating the relationship between mental and physical health and their shared risk factors and outcomes using data from TwinsUK<\/a> <\/span>and the Twins Early Development Study (TEDS)<\/span><\/a>. She has expertise in working with large longitudinal datasets, particularly birth cohort studies, to explore environmental risk and protective factors associated with mental health across the life course.<\/p>\nDr Milla Kibble, Research Facilitator, University of Cambridge<\/h3>\n
Milla Kibble (nee Anttila) received her PhD in high dimensional convex geometry and probability theory (Pure Mathematics) from UCL in
![\"Headshot](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/milla-kibble_circ.png\")
2000. She subsequently worked at Numbercraft Ltd. in Oxford, developing and employing analytics techniques to gain actionable information from large datasets. From 2002 to 2014, Milla combined undergraduate and postgraduate teaching of mathematics and statistics with research into probability and graph theory applications to biological data first in the Biomathematics Group at the University of Turku and then in the Stochastics Group at Aalto University in Finland.<\/p>\nIn 2014, Milla joined the Institute for Molecular Medicine Finland (FIMM) as a senior researcher, working first in the Computational Systems Medicine Group, where her research focused on network pharmacology approaches to provide systems-level insights into the mechanisms of action of natural products; and as of 2017 in the Epigenetics of Complex Diseases and Traits Group, using multiple data types from monozygotic twins to gain insights into the role of epigenetic effects in obesity.<\/p>\n
In 2018, Milla joined the Department of Applied Mathematics and Theoretical Physics (DAMTP) at the University of Cambridge as the new Research Facilitator, where her role broadly speaking is to support and develop the research strategy at DAMTP. In August 2021, Milla was awarded an MRC Fellowship to be seconded to the Longitudinal Health and Wellbeing NCS for COVID-19 for one year. She is working with Professor Nic Timpson at the University of Bristol and Dr Claire Steves at KCL to investigate the biological and societal factors behind differential response to COVID-19 vaccination and infection.<\/p>\n
[\/et_pb_accordion_item][et_pb_accordion_item title=”Day 2″ open=”off” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Mr Allan Bennett, UK Health Security Agency<\/h3>\n
Dr Simon Parker, Defence Science and Technology Laboratory<\/h3>\n
Professor Martie Van Tongeren, University of Manchester<\/h3>\n
Martie van Tongeren<\/a><\/span>, Professor of occupational and environmental health at the University of Manchester, has nearly 30 years of
![\"Circular](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2021\/09\/martie-van-tongeren.jpg\")
experience in research in occupational and environmental exposure assessment and epidemiology, including more than 10 years at the Institute of Occupational Medicine (IOM) in Edinburgh most recently as Head of Exposure Assessment\/Director of Research Development. His main research projects include development and application of tools to estimate current and past exposure to various chemical and other agents in the work environment and the home for chemical risk assessment and epidemiological studies.<\/p>\n![\"Headshot](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/02\/Yiqun-Chen.png\")
Dr Yiqun Chen, HSE<\/h3>\nDr Jennifer Anderson, Head of Training and Careers, UKRI, Medical Research Council<\/h3>\n
Dr Jennifer Anderson is Head of Training and Careers (MRC). Her role involves overseeing MRC\u2019s strategy for, and investment in,
studentships and personal fellowships to ensure we train, attract and retain the skilled individuals that make the UK a leader in biomedical research. Prior to joining MRC in 2015, she completed a PhD in cancer cell biology and spent 8 years as a postdoc researching radiation biology.<\/p>\nDr Beth Routley, Senior Researcher, Secure Research Service,ONS<\/h3>\n
<\/p>\n
[\/et_pb_accordion_item][\/et_pb_accordion][et_pb_text admin_label=”Title: Lightning Talks” _builder_version=”3.17.6″]<\/p>\n
Lightning Talks<\/h2>\n
[\/et_pb_text][et_pb_accordion admin_label=”Accordion: Lightning Talks” _builder_version=”3.17.6″ border_color_all=”#ffffff” use_border_color=”off”][et_pb_accordion_item title=”Session A – Modelling\/Transmission” open=”on” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Chair: David Fishwick<\/h2>\n
David is a Consultant Respiratory Physician in the NHS in Sheffield and the Chief Medical Adviser to the Health and Safety Executive. He holds honorary Professorships in Respiratory Medicine at the Universities of Sheffield and Manchester. He is a Co-Director of the Centre for Workplace Health and a member of the UK Independent Scientific Advisory Committee. David is the outgoing Chair of the European Respiratory Society Occupational and Environmental Group. He works actively within the PROTECT study, particularly within Theme 3. He also sat on the HSE-based Decision Making Group for PPE clearance during the COVID-19 pandemic, and actively contributes to much of the work of the Thomas Ashton Institute for Risk and Regulatory Research<\/span><\/a> with The University of Manchester.<\/p>\n
Transmission of SARS-CoV-2 in real world setting and experimental models<\/strong>
Jie Zhou (Jay)
<\/em>Access a PDF: Transmission of SARS-CoV-2 in real world setting and experimental models<\/a><\/span><\/p>\nAsymptomatic\/mild SARS-CoV-2 Skin-Skin & Bio-aerosols Transmission<\/strong>
Amanda Seekings
<\/em>Access a PDF: Asymptomatic\/mild SARS-CoV-2 Skin-Skin & Bio-aerosols Transmission<\/span><\/a><\/p>\nModelling SARS-CoV-2 transmission risk on a construction site<\/strong>
Clara<\/span><\/a> Cheung<\/span><\/a>, Thomas Ashton Institute for Risk and Regulatory Research, University of Manchester<\/em><\/p>\nTalk 1: Simplified Within Host and Dose-response Models of SARS-CoV-2 Infection<\/strong>
Jingsi Xu<\/em><\/p>\nTalk 2: Using in-host models to advise on social care asymptomatic testing strategies<\/strong>
Ian Hall<\/a><\/span>, University of Manchester
<\/em>Access a PDF: Using in-host models to advise on social care asymptomatic testing strategies<\/a><\/span><\/p>\nAI-assisted observation of micro-activities to estimate microbial exposure<\/strong>
Tom Komar, Urban Observatory at Newcastle University
<\/em>Access a PDF:AI-assisted observation of micro-activities to estimate microbial exposure<\/a><\/span><\/p>\nTom’s role at Urban Observatory is to develop applications for analysis of sensor data and imagery. Software he builds forms numerous
![\"Headshot](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2022\/05\/tom-komar_circ.png\")
micro-services in the UO stack, and forms parts of the data capture, analysis and presentation systems. Machine Learning methods developed at the Urban Observatory extract quantitative data from imagery, cluster information for efficient time-series management, and highlight suspicious sensor readings. They are used to enrich captured observations, enhance archiving and retrieval of information, and improve data quality for use in research.<\/p>\nBefore joining the Urban Observatory he worked in transport modelling and urban planning, where he created travel demand models and urban development simulations.<\/p>\n
Changes In Ventilation of Schools when monitoring CO2 (CIVOS)<\/strong>
Natalie Williams
<\/em>Access a PDF: Changes In Ventilation of Schools when monitoring CO2 (CIVOS)<\/span><\/a><\/p>\nDr Williams is a Behavioural Scientist with the Behavioural Science and Insights Unit (BSIU). The BSIU coordinate behavioural and social science advice, guidance, evaluation and research within the UK Health Security Agency.<\/p>\n
[\/et_pb_accordion_item][et_pb_accordion_item title=”Session B – COVID-19 Prevalence and More” open=”off” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Chair: Martie Van Tongeren<\/h2>\n
Martie van Tongeren is Professor of Occupational & Environmental Health the University of Manchester. He has nearly 30 years of
experience in research in occupational and environmental exposure assessment and epidemiology, including more than 10 years at the Institute of Occupational Medicine (IOM) in Edinburgh most recently as Head of Exposure Assessment\/Director of Research Development. His main research projects include development and application of tools to estimate current and past exposure to various chemical and other agents in the work environment and the home for chemical risk assessment and epidemiological studies.<\/p>\nRe-imagining construction project delivery in a post-pandemic economy<\/strong>
Richard Kirkham<\/a>,<\/span> Thomas Ashton Institute for Risk and Regulatory Research, University of Manchester
<\/em>Access a PDF: Re-imagining construction project delivery in a post-pandemic economy copy of the presentation<\/a><\/span><\/p>\nAreas of enduring COVID-19 prevalence<\/strong>
![\"Headshot](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2021\/11\/Cath-Lewis_circ.png\")
Cath Lewis, University of Manchester
<\/em>Access a PDF: Areas of enduring COVID-19 prevalence<\/a><\/span><\/p>\nCath is one of the lead researchers on a PROTECT project looking at enduring prevalence of COVID-19, and contributes to several other projects within PROTECT, including a systematic review of risk factors for workplace transmission. She has a background in nursing and has previously worked on a wide range of research projects including a qualitative evaluation of health care provision within secure settings, a review of the health impacts of COVID-19 and a qualitative evaluation of a regional contact tracing system.<\/p>\n
Understanding community level influences on COVID-19 prevalence in England<\/strong>
Chaitanya Joshi
<\/em>Access a PDF: Understanding community level influences on COVID-19 prevalence in England<\/a><\/span><\/p>\nIdentifying targets for interventions to increase the wearing of face coverings<\/strong>
Chris Armitage, University of Manchester<\/em><\/p>\nUsing WGS-enriched contact tracing data at national scale to understand SARS-CoV-2 transmission<\/strong>
Charlie Turner, Contact Tracing Data Team, UK Health Security Agency
<\/em>Access a PDF: Using WGS-enriched contact tracing data at national scale to understand SARS-CoV-2 transmission<\/a><\/span><\/p>\nSpatial clustering of COVID-19 contact tracing data<\/strong>
Rachel Abbey
<\/em>Access a PDF: Methodology for the Spatial Clustering of CTAS data to identify high risk workplace settings<\/a><\/span><\/p>\nKeeping the UK Building Safely (KUBS)<\/strong>
![\"\"](\"https:\/\/sites.manchester.ac.uk\/covid19-national-project\/wp-content\/uploads\/sites\/276\/2021\/10\/sheena_circ.png\")
Sheena Johnson, Thomas Ashton Institute for Risk and Regulatory Research, University of Manchester
<\/em>Access a PDF: Keeping the UK Building Safely (KUBS)<\/a><\/span><\/p>\nSheena Johnson is an Occupational and Chartered Psychologist registered with the Health and Care Professions Council, and Professor of Work Psychology and Wellbeing at Alliance Manchester Business School. She is an active researcher into the topics of stress and health and the ageing workforce. Sheena is the author of numerous journal articles and book chapters, regularly presents her work at national and international conferences and sits on the Editorial Board of the International Journal of Stress Management, an American Psychological Association journal, and the official journal of the International Stress Management Association.<\/p>\n
Sheena is the University of Manchester lead on Social Change and Inequalities at the Thomas Ashton Institute for Risk and Regulatory Research<\/span><\/a>, and sits on the management board of MICRA (Manchester Institute for Collaborative Research on Ageing). She is also a member of both Alliance Manchester Business School\u2019s Work and Equalities Research Institute where she is academic lead for theme 2 \u2018Fair Treatment at Work\u2019, and the Division of Occupational Psychology\u2019s Health and Well-Being Working Group.<\/p>\n
Mitigating transmission in a shared meeting room scenario<\/strong>
Daniel Miller
<\/em>Access a PDF: Mitigating transmission in a shared meeting room scenario<\/a><\/span><\/p>\n[\/et_pb_accordion_item][et_pb_accordion_item title=”Session C – Experimental\/ Measurements” open=”off” _builder_version=”3.17.6″ title_text_shadow_horizontal_length=”0em” title_text_shadow_vertical_length=”0em” title_text_shadow_blur_strength=”0em” body_text_shadow_horizontal_length=”0em” body_text_shadow_vertical_length=”0em” body_text_shadow_blur_strength=”0em”]<\/p>\n
Chair: Allan Bennett<\/h2>\n
Flow in and around face masks<\/strong>
Caroline Marshall
<\/em>Access a PDF: Flow in and around face masks<\/a><\/span><\/p>\nImaging aerosol deposition and filtration with advanced x-ray microscopies<\/strong>
David Eastwood<\/span><\/a>, University of Manchester at Harwell
<\/em>Access a PDF: Imaging aerosol deposition and filtration with advanced x-ray microscopies<\/a><\/span><\/p>\nDavid’s work deals with resilience – improving the scientific knowledge base underpinning decisions about potential hazards and how we respond to them. He is particularly interested in reactive materials such as batteries and catalysts, and airborne materials such as aerosols and particulate matter. David is based at the Diamond Light Source in Oxfordshire as part of the University of Manchester at Harwell<\/span><\/a>‘s Collaboration with Diamond,<\/span> where he develops X-ray imaging and in situ<\/em> synchrotron techniques, and is a member of the Department of Mechanical, Aerospace and Civil Engineering<\/span>, <\/a>University of Manchester,<\/p>\n
Talk 1: Bacterial signals captured from aerosols vary between different breathing activities, different sampling matrices and different microbial identities inform development of face mask sampling<\/strong>
Mohamad Abdulwhhab
<\/em>Access a PDF: Bacterial signals captured from aerosols vary between different breathing activities, different sampling matrices and different microbial identities inform development of face mask sampling<\/a><\/span><\/p>\nTalk 2: The utilisation of facemask sampling for the detection of SARS-CoV-2<\/strong>
Jonathan Decker
<\/em><\/p>\nEvaluation of SARS-CoV-2 environmental surface sampling protocols<\/strong>
Antony Spencer
<\/em>Access a PDF: Evaluation of SARS-CoV-2 environmental surface sampling protocols<\/span><\/a><\/p>\nValidation of viability qPCR<\/strong>
Ian Nicholls<\/em><\/p>\nInvestigation of Aerosol Stability of SARS-CoV-2 Alpha, Beta and Delta Variants of Concern at Low, Medium and High Relative Humidity (RH)